Yuming Zhu

3.0k total citations
110 papers, 1.5k citations indexed

About

Yuming Zhu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yuming Zhu has authored 110 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 26 papers in Surgery. Recurrent topics in Yuming Zhu's work include Lung Cancer Diagnosis and Treatment (59 papers), Lung Cancer Treatments and Mutations (30 papers) and Pleural and Pulmonary Diseases (22 papers). Yuming Zhu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (59 papers), Lung Cancer Treatments and Mutations (30 papers) and Pleural and Pulmonary Diseases (22 papers). Yuming Zhu collaborates with scholars based in China, Spain and United States. Yuming Zhu's co-authors include Gening Jiang, Diego González-Rivas, Deping Zhao, Lei Jiang, Dong Xie, Chang Chen, Liang Duan, Jie Dai, Yang Yang and Yuexin Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Yuming Zhu

103 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuming Zhu China 21 901 368 267 259 152 110 1.5k
Siyu Wang China 21 890 1.0× 631 1.7× 138 0.5× 274 1.1× 200 1.3× 131 1.5k
Qun Zhao China 21 451 0.5× 364 1.0× 282 1.1× 493 1.9× 352 2.3× 133 1.3k
Dong Chen China 19 549 0.6× 189 0.5× 206 0.8× 351 1.4× 196 1.3× 101 1.3k
Yu–Chung Wu Taiwan 25 1.1k 1.2× 585 1.6× 368 1.4× 353 1.4× 230 1.5× 62 2.0k
Shiro Mizuno Japan 23 1.5k 1.7× 160 0.4× 263 1.0× 582 2.2× 338 2.2× 70 2.1k
Shinjiro Mizuguchi Japan 20 401 0.4× 186 0.5× 183 0.7× 333 1.3× 41 0.3× 69 1.0k
Carla L. Ellis United States 20 318 0.4× 131 0.4× 259 1.0× 287 1.1× 101 0.7× 45 995
Yasuaki Hirooka Japan 24 216 0.2× 341 0.9× 243 0.9× 595 2.3× 206 1.4× 88 1.4k
Mahesh Parmar United Kingdom 9 337 0.4× 357 1.0× 612 2.3× 165 0.6× 172 1.1× 12 1.5k

Countries citing papers authored by Yuming Zhu

Since Specialization
Citations

This map shows the geographic impact of Yuming Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuming Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuming Zhu more than expected).

Fields of papers citing papers by Yuming Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuming Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuming Zhu. The network helps show where Yuming Zhu may publish in the future.

Co-authorship network of co-authors of Yuming Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuming Zhu. A scholar is included among the top collaborators of Yuming Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuming Zhu. Yuming Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ke, Bin Guan, Linlin Qin, et al.. (2025). Fe2O3 Hollow Multishelled Structure Endowed Temporal Sequential Mass Release for Apoptosis/Ferroptosis‐Induced Combined Cancer Therapy. Advanced Functional Materials. 35(20). 2 indexed citations
2.
Bian, Dongliang, Wentian Zhang, Fenghuan Sun, et al.. (2025). Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA–IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial. BMC Medicine. 23(1). 429–429. 1 indexed citations
3.
Sun, Liangdong, Jue Wang, Huansha Yu, et al.. (2025). Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma. Communications Biology. 8(1). 152–152. 1 indexed citations
4.
Guo, Liang, et al.. (2023). Overexpression of VEGFA mediated by HIF‐1 is associated with higher rate of spread through air spaces in resected lung adenocarcinomas. The Journal of Gene Medicine. 26(1). e3625–e3625. 1 indexed citations
5.
Zhu, Xianmin, Yuehua Gao, Yixiao Dong, et al.. (2023). DNA methylation in small cell lung cancer. SHILAP Revista de lepidopterología. 3(3).
6.
Zhang, Lei, Lang Xia, Long Xu, et al.. (2023). Perioperative outcomes comparison of robotic and video-assisted thoracoscopic thymectomy for thymic epithelial tumor: a single-center experience. Updates in Surgery. 76(4). 1511–1519. 2 indexed citations
7.
She, Yunlang, Yifan Zhong, Likun Hou, et al.. (2023). Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases. JTO Clinical and Research Reports. 4(3). 100465–100465. 5 indexed citations
8.
Wang, Xing, et al.. (2022). A novel drainage strategy using chest tube plus pleural catheter in uniportal upper lobectomy: A randomized controlled trial. Thoracic Cancer. 14(4). 399–406. 6 indexed citations
9.
Bao, Yi, Chao Jiang, Yang Wang, et al.. (2022). Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer. Interactive Cardiovascular and Thoracic Surgery. 35(2). 6 indexed citations
11.
Bao, Yi, Chang Gu, Huikang Xie, et al.. (2021). Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer. Annals of Translational Medicine. 9(6). 493–493. 14 indexed citations
12.
Xie, Dong, Junqi Wu, Xuefei Hu, et al.. (2020). Uniportal versus multiportal video-assisted thoracoscopic surgery does not compromise the outcome of segmentectomy. European Journal of Cardio-Thoracic Surgery. 59(3). 650–657. 18 indexed citations
13.
Deng, Jiajun, Mengmeng Zhao, Tingting Wang, et al.. (2020). A modified T categorization for part-solid lesions in Chinese patients with clinical stage I Non–small cell lung cancer. Lung Cancer. 145. 33–39. 16 indexed citations
14.
Wang, Xing, Xiaofang You, Beatrice Aramini, et al.. (2020). Extended Sleeve Lobectomy is an Alternative for Centrally Located Lung Cancer With Superior Short- and Long-term Outcomes. Clinical Lung Cancer. 22(4). e621–e628. 6 indexed citations
15.
Peng, Qiao, Lei Zhang, Yijiu Ren, et al.. (2019). Reconstruction of Long Noncircumferential Tracheal or Carinal Resections With Bronchial Flaps. The Annals of Thoracic Surgery. 108(2). 417–423. 3 indexed citations
16.
Sihoe, Alan, et al.. (2018). High-volume intensive training course: a new paradigm for video-assisted thoracoscopic surgery education. Interactive Cardiovascular and Thoracic Surgery. 27(3). 365–371. 10 indexed citations
17.
Zhu, Yuming, et al.. (2017). Bilateral uniportal video-assisted thoracic surgery segmentectomy S3: an unusual case. Journal of Visualized Surgery. 3(11). 168–168.
18.
Akar, Firas Abu, et al.. (2017). Thoracoscopic tracheal resection and reconstruction using two ports approach. Journal of Visualized Surgery. 2. 19–19. 5 indexed citations
19.
Chen, Qiankun, Gening Jiang, Jia-an Ding, et al.. (2013). Complications in the native lung after single lung transplantation. 34(4). 235–238. 2 indexed citations
20.
Zhu, Yuming, Yi Zhang, & Gening Jiang. (2008). Bronchoplastic lobectomy in non-small cell lung cancer: review of 218 patients. 24(4). 228–230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026